Our team

Senior Researcher and Entrepreneur Fellow at the University of Zurich with over 15 years of experience in biochemistry, chemistry, and molecular biology. He obtained his PhD from the Technion (Israel) and completed his postdoctoral training at the University of Zurich. His research focuses on engineering genetically encoded biosensors for drug screening and developing novel inhibitors as drug candidates. His work has resulted in 14 scientific publications and 3 patents.

Roman Meledin, PhD

Co-founder and CEO

Full Professor of Immunology at the University of Zurich with deep expertise in cytokine biology and translational immunotherapy. He is the founder and CEO/Chairman of SEITO Biologics and co-founder of Anaveon, bringing extensive experience in academic–industry translation, clinical development, and IP strategy in immunology.

Thi Nguyen, PhD

Co-founder and CSO

Onur Boyman, MD

Co-founder and director

Senior researcher and BRIDGE fellow at the University of Zurich with over 7 years of experience in immunology and drug discovery. She obtained her MSc at ETH Zurich and her PhD at the University of Zurich. Dr. Nguyen co-developed an IP-protected drug-screening platform for JAK and STAT inhibitor discovery, published in Nature Chemical Biology, and leads assay development and implementation.